Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1995 Jul;8(3):317–335. doi: 10.1128/cmr.8.3.317

Cutaneous defenses against dermatophytes and yeasts.

D K Wagner 1, P G Sohnle 1
PMCID: PMC174627  PMID: 7553568

Abstract

Predispositions to the superficial mycoses include warmth and moisture, natural or iatrogenic immunosuppression, and perhaps some degree of inherited susceptibility. Some of these infections elicit a greater inflammatory response than others, and the noninflammatory ones are generally more chronic. The immune system is involved in the defense against these infections, and cell-mediated immunity appears to be particularly important. The mechanisms involved in generating immunologic reactions in the skin are complex, with epidermal Langerhans cells, other dendritic cells, lymphocytes, microvascular endothelial cells, and the keratinocytes themselves all participating in one way or another. A variety of defects in the immunologic response to the superficial mycoses have been described. In some cases the defect may be preexistent, whereas in others the infection itself may interfere with protective cell-mediated immune responses against the organisms. A number of different mechanisms may underlie these immunologic defects and lead to the development of chronic superficial fungal infection in individual patients. Although the immunologic defects appear to be involved in the chronicity of certain types of cutaneous fungal infections, treatment of these defects remains experimental at the present time.

Full Text

The Full Text of this article is available as a PDF (399.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiba S., Katz S. I. The ability of cultured Langerhans cells to process and present protein antigens is MHC-dependent. J Immunol. 1991 Apr 15;146(8):2479–2487. [PubMed] [Google Scholar]
  2. Ajello L. Natural history of the dermatophytes and related fungi. Mycopathol Mycol Appl. 1974 Aug 30;53(1):93–110. doi: 10.1007/BF02127200. [DOI] [PubMed] [Google Scholar]
  3. Alexander S. Loss of hair and dandruff. Br J Dermatol. 1967 Oct;79(10):549–552. doi: 10.1111/j.1365-2133.1967.tb11411.x. [DOI] [PubMed] [Google Scholar]
  4. Alspaugh J. A., Granger D. L. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun. 1991 Jul;59(7):2291–2296. doi: 10.1128/iai.59.7.2291-2296.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Arnold R. R., Brewer M., Gauthier J. J. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun. 1980 Jun;28(3):893–898. doi: 10.1128/iai.28.3.893-898.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Arnold R. R., Russell J. E., Champion W. J., Gauthier J. J. Bactericidal activity of human lactoferrin: influence of physical conditions and metabolic state of the target microorganism. Infect Immun. 1981 May;32(2):655–660. doi: 10.1128/iai.32.2.655-660.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Astier A., de la Salle H., de la Salle C., Bieber T., Esposito-Farese M. E., Freund M., Cazenave J. P., Fridman W. H., Teillaud J. L., Hanau D. Human epidermal Langerhans cells secrete a soluble receptor for IgG (Fc gamma RII/CD32) that inhibits the binding of immune complexes to Fc gamma R+ cells. J Immunol. 1994 Jan 1;152(1):201–212. [PubMed] [Google Scholar]
  8. Axelsen N. H., Kirkpatrick C. H., Buckley R. H. Precipitins to Candida albicans in chronic mucocutaneous candidiasis studied by crossed immunoelectrophoresis with intermediate gel. Correlation with clinical and immunological findings. Clin Exp Immunol. 1974 Jul;17(3):385–394. [PMC free article] [PubMed] [Google Scholar]
  9. BAER R. L., ROSENTHAL S. A., FURNARI D. Survival of dermatophytes applied on the feet. J Invest Dermatol. 1955 Jun;24(6):619–622. doi: 10.1038/jid.1955.83. [DOI] [PubMed] [Google Scholar]
  10. BARKER S. A., CRUICKSHANK C. N., MORRIS J. H., WOOD S. R. The isolation of trichophytin glycopeptide and its structure in relation to the immediate and delayed reactions. Immunology. 1962 Nov;5:627–632. [PMC free article] [PubMed] [Google Scholar]
  11. BONK A. F., FRIEDMAN L., DERBES V. J. Experimental dermatophytosis. J Invest Dermatol. 1962 Oct;39:281–286. doi: 10.1038/jid.1962.113. [DOI] [PubMed] [Google Scholar]
  12. BURKE R. C. Tinea versicolor: susceptibility factors and experimental infection in human beings. J Invest Dermatol. 1961 May;36:389–402. doi: 10.1038/jid.1961.60. [DOI] [PubMed] [Google Scholar]
  13. Bal V., McIndoe A., Denton G., Hudson D., Lombardi G., Lamb J., Lechler R. Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol. 1990 Sep;20(9):1893–1897. doi: 10.1002/eji.1830200904. [DOI] [PubMed] [Google Scholar]
  14. Barker J. N., Jones M. L., Mitra R. S., Crockett-Torabe E., Fantone J. C., Kunkel S. L., Warren J. S., Dixit V. M., Nickoloff B. J. Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am J Pathol. 1991 Oct;139(4):869–876. [PMC free article] [PubMed] [Google Scholar]
  15. Barker J. N., Jones M. L., Swenson C. L., Sarma V., Mitra R. S., Ward P. A., Johnson K. J., Fantone J. C., Dixit V. M., Nickoloff B. J. Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-gamma. J Immunol. 1991 Feb 15;146(4):1192–1197. [PubMed] [Google Scholar]
  16. Bennett K., Levine T., Ellis J. S., Peanasky R. J., Samloff I. M., Kay J., Chain B. M. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur J Immunol. 1992 Jun;22(6):1519–1524. doi: 10.1002/eji.1830220626. [DOI] [PubMed] [Google Scholar]
  17. Bergbrant I. M., Faergemann J. Variations of Pityrosporum orbiculare in middle-aged and elderly individuals. Acta Derm Venereol. 1988;68(6):537–540. [PubMed] [Google Scholar]
  18. Bergbrant I. M., Johansson S., Robbins D., Scheynius A., Faergemann J., Söderström T. An immunological study in patients with seborrhoeic dermatitis. Clin Exp Dermatol. 1991 Sep;16(5):331–338. doi: 10.1111/j.1365-2230.1991.tb00395.x. [DOI] [PubMed] [Google Scholar]
  19. Berger M., Kirkpatrick C. H., Goldsmith P. K., Gallin J. I. IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections. J Immunol. 1980 Dec;125(6):2437–2443. [PubMed] [Google Scholar]
  20. Bergstresser P. R., Cruz P. D., Jr, Niederkorn J. Y., Takashima A. Third International Workshop on Langerhans cells: discussion overview. J Invest Dermatol. 1992 Nov;99(5):1S–4S. doi: 10.1111/1523-1747.ep12668192. [DOI] [PubMed] [Google Scholar]
  21. Berk S. H., Penneys N. S., Weinstein G. D. Epidermal activity in annular dermatophytosis. Arch Dermatol. 1976 Apr;112(4):485–488. [PubMed] [Google Scholar]
  22. Bevilacqua M. P., Pober J. S., Mendrick D. L., Cotran R. S., Gimbrone M. A., Jr Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9238–9242. doi: 10.1073/pnas.84.24.9238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Bibel D. J., Aly R., Shah S., Shinefield H. R. Sphingosines: antimicrobial barriers of the skin. Acta Derm Venereol. 1993 Dec;73(6):407–411. doi: 10.2340/0001555573407411. [DOI] [PubMed] [Google Scholar]
  24. Bice D. E., Lopez M., Rothschild H., Salvaggio J. Comparison of Candida-delayed hypersensitivity skin test size with lymphocyte transformation, migration inhibitory factor production and antibody titer. Int Arch Allergy Appl Immunol. 1974;47(1):54–62. doi: 10.1159/000231200. [DOI] [PubMed] [Google Scholar]
  25. Bieber T. IgE-binding molecules on human Langerhans cells. Acta Derm Venereol Suppl (Stockh) 1992;176:54–57. [PubMed] [Google Scholar]
  26. Bieber T., de la Salle H., de la Salle C., Hanau D., Wollenberg A. Expression of the high-affinity receptor for IgE (Fc epsilon RI) on human Langerhans cells: the end of a dogma. J Invest Dermatol. 1992 Nov;99(5):10S–11S. doi: 10.1111/1523-1747.ep12668204. [DOI] [PubMed] [Google Scholar]
  27. Blake J. S., Dahl M. V., Herron M. J., Nelson R. D. An immunoinhibitory cell wall glycoprotein (mannan) from Trichophyton rubrum. J Invest Dermatol. 1991 May;96(5):657–661. doi: 10.1111/1523-1747.ep12470582. [DOI] [PubMed] [Google Scholar]
  28. Blank H., Taplin D., Zaias N. Cutaneous Trichophyton mentagrophytes infections in Vietnam. Arch Dermatol. 1969 Feb;99(2):135–144. [PubMed] [Google Scholar]
  29. Bos J. D., Teunissen M. B., Cairo I., Krieg S. R., Kapsenberg M. L., Das P. K., Borst J. T-cell receptor gamma delta bearing cells in normal human skin. J Invest Dermatol. 1990 Jan;94(1):37–42. doi: 10.1111/1523-1747.ep12873333. [DOI] [PubMed] [Google Scholar]
  30. Bufill J. A., Lum L. G., Caya J. G., Chitambar C. R., Ritch P. S., Anderson T., Ash R. C. Pityrosporum folliculitis after bone marrow transplantation. Clinical observations in five patients. Ann Intern Med. 1988 Apr;108(4):560–563. doi: 10.7326/0003-4819-108-4-560. [DOI] [PubMed] [Google Scholar]
  31. Burford-Mason A. P., Matthews R. C., Williams J. R. Transient abrogation of immunosuppression in a patient with chronic mucocutaneous candidiasis following vaccination with Candida albicans. J Infect. 1987 Mar;14(2):147–157. doi: 10.1016/s0163-4453(87)91977-3. [DOI] [PubMed] [Google Scholar]
  32. Bäck O., Faergemann J., Hörnqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol. 1985 Jan;12(1 Pt 1):56–61. doi: 10.1016/s0190-9622(85)70009-6. [DOI] [PubMed] [Google Scholar]
  33. CANIZARES O., SHATIN H., KELLERT A. J. Cushing's syndrome and dermatomycosis. Arch Dermatol. 1959 Dec;80:705–712. doi: 10.1001/archderm.1959.01560240057007. [DOI] [PubMed] [Google Scholar]
  34. CRUICKSHANK C. N., TROTTER M. D., WOOD S. R. Studies on tricophytin sensitivity. J Invest Dermatol. 1960 Oct;35:219–223. [PubMed] [Google Scholar]
  35. Cahill L. T., Ainbender E., Glade P. R. Chronic mucocutaneous candidiasis: T cell deficiency associated with B cell dysfunction in man. Cell Immunol. 1974 Nov;14(2):215–225. doi: 10.1016/0008-8749(74)90207-x. [DOI] [PubMed] [Google Scholar]
  36. Calderon R. A., Hay R. J. Fungicidal activity of human neutrophils and monocytes on dermatophyte fungi, Trichophyton quinckeanum and Trichophyton rubrum. Immunology. 1987 Jul;61(3):289–295. [PMC free article] [PubMed] [Google Scholar]
  37. Calderon R. A., Hay R. J., Shennan G. I. Circulating antigens and antibodies in human and mouse dermatophytosis: use of monoclonal antibody reactive to phosphorylcholine-like epitopes. J Gen Microbiol. 1987 Sep;133(9):2699–2705. doi: 10.1099/00221287-133-9-2699. [DOI] [PubMed] [Google Scholar]
  38. Calderon R. A. Immunoregulation of dermatophytosis. Crit Rev Microbiol. 1989;16(5):339–368. doi: 10.3109/10408418909104472. [DOI] [PubMed] [Google Scholar]
  39. Campanelli D., Detmers P. A., Nathan C. F., Gabay J. E. Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J Clin Invest. 1990 Mar;85(3):904–915. doi: 10.1172/JCI114518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Carrow E. W., Domer J. E. Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein. Infect Immun. 1985 Jul;49(1):172–181. doi: 10.1128/iai.49.1.172-181.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature. 1992 Nov 19;360(6401):258–261. doi: 10.1038/360258a0. [DOI] [PubMed] [Google Scholar]
  42. Chappler R. R., Maibach H. I., Conant M. A. Mucocutaneous candidiasis or mucocutaneous microbiosis? JAMA. 1978 Jan 30;239(5):428–429. [PubMed] [Google Scholar]
  43. Chipps B. E., Saulsbury F. T., Hsu S. H., Hughes W. T., Winkelstein J. A. Non-candidal infections in children with chronic mucocutaneous candidiasis. Johns Hopkins Med J. 1979 Jun;144(6):175–179. [PubMed] [Google Scholar]
  44. Chugh K. S., Sharma S. C., Singh V., Sakhuja V., Jha V., Gupta K. L. Spectrum of dermatological lesions in renal allograft recipients in a tropical environment. Dermatology. 1994;188(2):108–112. doi: 10.1159/000247112. [DOI] [PubMed] [Google Scholar]
  45. Coffman R. L., Ohara J., Bond M. W., Carty J., Zlotnik A., Paul W. E. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol. 1986 Jun 15;136(12):4538–4541. [PubMed] [Google Scholar]
  46. Collins M. S., Pappagianis D. Inhibition by lysozyme of growth of the spherule phase of Coccidioides immitis in vitro. Infect Immun. 1974 Sep;10(3):616–623. doi: 10.1128/iai.10.3.616-623.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Concha M., Vidal A., Garcés G., Figueroa C. D., Caorsi I. Physical interaction between Langerhans cells and T-lymphocytes during antigen presentation in vitro. J Invest Dermatol. 1993 Apr;100(4):429–434. doi: 10.1111/1523-1747.ep12472117. [DOI] [PubMed] [Google Scholar]
  48. Cox W. A., Moore J. A. Experimental Trichophyton verrucosum infections in laboratory animals. J Comp Pathol. 1968 Jan;78(1):35–41. doi: 10.1016/0021-9975(68)90110-2. [DOI] [PubMed] [Google Scholar]
  49. Crosby D. L., Berger T. G., Woosley J. T., Resnick S. D. Dermatophytosis mimicking Kaposi's sarcoma in human immunodeficiency virus disease. Dermatologica. 1991;182(2):135–137. doi: 10.1159/000247763. [DOI] [PubMed] [Google Scholar]
  50. Cumberbatch M., Gould S. J., Peters S. W., Kimber I. MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization. Immunology. 1991 Nov;74(3):414–419. [PMC free article] [PubMed] [Google Scholar]
  51. Cunningham A. L., Noble J. R. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro. J Clin Invest. 1989 Feb;83(2):490–496. doi: 10.1172/JCI113908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Cutler J. E. Chemotactic factor produced by Candida albicans. Infect Immun. 1977 Dec;18(3):568–573. doi: 10.1128/iai.18.3.568-573.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. DaMert G. J., Kirkpatrick C. H., Sohnle P. G. Comparison of antibody responses in chronic mucocutaneous candidiasis and tinea versicolor. Int Arch Allergy Appl Immunol. 1980;63(1):97–104. doi: 10.1159/000232614. [DOI] [PubMed] [Google Scholar]
  54. Davies R. R., Zaini F. Enzymic activities of Trichophyton rubrum and the chemotaxis of polymorphonuclear leucocytes. Sabouraudia. 1984;22(3):235–241. [PubMed] [Google Scholar]
  55. Davies R. R., Zaini F. Trichophyton rubrum and the chemotaxis of polymorphonuclear leucocytes. Sabouraudia. 1984;22(1):65–71. [PubMed] [Google Scholar]
  56. De Panfilis G., Manara G. C., Ferrari C., Torresani C. Adhesion molecules on the plasma membrane of epidermal cells. III. Keratinocytes and Langerhans cells constitutively express the lymphocyte function-associated antigen 3. J Invest Dermatol. 1991 Apr;96(4):512–517. doi: 10.1111/1523-1747.ep12470220. [DOI] [PubMed] [Google Scholar]
  57. Drazin R. E., Lehrer R. I. Fungicidal properties of a chymotrypsin-like cationic protein from human neutrophils: adsorption to Candida parapsilosis. Infect Immun. 1977 Aug;17(2):382–388. doi: 10.1128/iai.17.2.382-388.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Drouhet E., Dupont B. Chronic mucocutaneous candidosis and other superficial and systemic mycoses successfully treated with ketoconazole. Rev Infect Dis. 1980 Jul-Aug;2(4):606–619. doi: 10.1093/clinids/2.4.606. [DOI] [PubMed] [Google Scholar]
  59. Durandy A., Fischer A., Le Deist F., Drouhet E., Griscelli C. Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. J Clin Immunol. 1987 Sep;7(5):400–409. doi: 10.1007/BF00917018. [DOI] [PubMed] [Google Scholar]
  60. Dustin M. L., Rothlein R., Bhan A. K., Dinarello C. A., Springer T. A. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986 Jul 1;137(1):245–254. [PubMed] [Google Scholar]
  61. Dustin M. L., Singer K. H., Tuck D. T., Springer T. A. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med. 1988 Apr 1;167(4):1323–1340. doi: 10.1084/jem.167.4.1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Elewski B. E., Greer D. L. Hendersonula toruloidea and Scytalidium hyalinum. Review and update. Arch Dermatol. 1991 Jul;127(7):1041–1044. [PubMed] [Google Scholar]
  63. Enk A. H., Angeloni V. L., Udey M. C., Katz S. I. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J Immunol. 1993 May 1;150(9):3698–3704. [PubMed] [Google Scholar]
  64. Espiritu B. R., Szpindor-Watson A., Zeitz H. J., Thomas L. L. IgE-mediated sensitivity to Trichophyton rubrum in a patient with chronic dermatophytosis and Cushing's syndrome. J Allergy Clin Immunol. 1988 May;81(5 Pt 1):847–851. doi: 10.1016/0091-6749(88)90941-4. [DOI] [PubMed] [Google Scholar]
  65. Faergemann J. Antibodies to Pityrosporum orbiculare in patients with tinea versicolor and controls of various ages. J Invest Dermatol. 1983 Feb;80(2):133–135. doi: 10.1111/1523-1747.ep12532935. [DOI] [PubMed] [Google Scholar]
  66. Faergemann J., Fredriksson T. Age incidence of Pityrosporum orbiculare on human skin. Acta Derm Venereol. 1980;60(6):531–533. [PubMed] [Google Scholar]
  67. Faergemann J., Gisslén H., Dahlberg E., Westin J., Roupe G. Trichophyton rubrum abscesses in immunocompromised patients. A case report. Acta Derm Venereol. 1989;69(3):244–247. [PubMed] [Google Scholar]
  68. Faergemann J., Johansson S., Bäck O., Scheynius A. An immunologic and cultural study of Pityrosporum folliculitis. J Am Acad Dermatol. 1986 Mar;14(3):429–433. doi: 10.1016/s0190-9622(86)70053-4. [DOI] [PubMed] [Google Scholar]
  69. Faergemann J., Maibach H. I. The Pityrosporon yeasts. Their role as pathogens. Int J Dermatol. 1984 Sep;23(7):463–465. doi: 10.1111/ijd.1984.23.7.463. [DOI] [PubMed] [Google Scholar]
  70. Ferguson A. C., Kershnar H. E., Collin W. K., Stiehm E. R. Correlation of cutaneous hypersensitivity with lymphocytic response to Candida albicans. Am J Clin Pathol. 1977 Oct;68(4):499–504. doi: 10.1093/ajcp/68.4.499. [DOI] [PubMed] [Google Scholar]
  71. Findling J. W., Tyrrell J. B., Aron D. C., Fitzgerald P. A., Young C. W., Sohnle P. G. Fungal infections in Cushing's syndrome. Ann Intern Med. 1981 Sep;95(3):392–392. doi: 10.7326/0003-4819-95-3-392_1. [DOI] [PubMed] [Google Scholar]
  72. Fischer A., Ballet J. J., Griscelli C. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis. J Clin Invest. 1978 Nov;62(5):1005–1013. doi: 10.1172/JCI109204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Fischer A., Pichat L., Audinot M., Griscelli C. Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness. Clin Exp Immunol. 1982 Mar;47(3):653–660. [PMC free article] [PubMed] [Google Scholar]
  74. Fleming T. E., Mirando W. S., Trefzer U., Tubesing K. A., Elmets C. A. In situ expression of a B7-like adhesion molecule on keratinocytes from human epidermis. J Invest Dermatol. 1993 Nov;101(5):754–758. doi: 10.1111/1523-1747.ep12371688. [DOI] [PubMed] [Google Scholar]
  75. Fredriksson T., Faergemann J. Semantics--tinea versus pityriasis versicolor and Pityrosporum orbiculare versus Malassezia furfur. Which is proper? Int J Dermatol. 1984 Mar;23(2):110–111. doi: 10.1111/j.1365-4362.1984.tb05682.x. [DOI] [PubMed] [Google Scholar]
  76. Fusaro R. M., Miller N. G. Onychomycosis caused by Trichosporon beigelii in the United States. J Am Acad Dermatol. 1984 Oct;11(4 Pt 2):747–749. doi: 10.1016/s0190-9622(84)70235-0. [DOI] [PubMed] [Google Scholar]
  77. Gabay J. E., Heiple J. M., Cohn Z. A., Nathan C. F. Subcellular location and properties of bactericidal factors from human neutrophils. J Exp Med. 1986 Nov 1;164(5):1407–1421. doi: 10.1084/jem.164.5.1407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Galbraith G. M. Therapeutic immunomodulation. Dermatol Clin. 1988 Oct;6(4):561–568. [PubMed] [Google Scholar]
  79. Ganz T., Selsted M. E., Szklarek D., Harwig S. S., Daher K., Bainton D. F., Lehrer R. I. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985 Oct;76(4):1427–1435. doi: 10.1172/JCI112120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Gaspari A. A., Katz S. I. Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes. J Immunol. 1988 May 1;140(9):2956–2963. [PubMed] [Google Scholar]
  81. Gaspari A. A., Katz S. I. Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes. J Immunol. 1991 Dec 15;147(12):4155–4161. [PubMed] [Google Scholar]
  82. Geng J. G., Bevilacqua M. P., Moore K. L., McIntyre T. M., Prescott S. M., Kim J. M., Bliss G. A., Zimmerman G. A., McEver R. P. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature. 1990 Feb 22;343(6260):757–760. doi: 10.1038/343757a0. [DOI] [PubMed] [Google Scholar]
  83. Gettner S. M., Mackenzie D. W. Responses of human peripheral lymphocytes to soluble and insoluble antigens of Candida albicans. J Med Microbiol. 1981 Aug;14(3):333–340. doi: 10.1099/00222615-14-3-333. [DOI] [PubMed] [Google Scholar]
  84. Gilchrest B. A. Some gerontologic considerations in the practice of dermatology. Arch Dermatol. 1979 Nov;115(11):1343–1346. [PubMed] [Google Scholar]
  85. Goodfield M. J., Saihan E. M., Crowley J. Experimental folliculitis with Pityrosporum orbiculare: the influence of host response. Acta Derm Venereol. 1987;67(5):445–447. [PubMed] [Google Scholar]
  86. Goodman R. E., Nestle F., Naidu Y. M., Green J. M., Thompson C. B., Nickoloff B. J., Turka L. A. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. J Immunol. 1994 Jun 1;152(11):5189–5198. [PubMed] [Google Scholar]
  87. Goodwin J. S. Prostaglandin regulation of mitogenesis. Cell Immunol. 1980 Jun;52(1):239–241. doi: 10.1016/0008-8749(80)90417-7. [DOI] [PubMed] [Google Scholar]
  88. Grabbe S., Bruvers S., Granstein R. D. Effects of immunomodulatory cytokines on the presentation of tumor-associated antigens by epidermal Langerhans cells. J Invest Dermatol. 1992 Nov;99(5):66S–68S. doi: 10.1111/1523-1747.ep12669018. [DOI] [PubMed] [Google Scholar]
  89. Grando S. A., Hostager B. S., Herron M. J., Dahl M. V., Nelson R. D. Binding of Trichophyton rubrum mannan to human monocytes in vitro. J Invest Dermatol. 1992 Jun;98(6):876–880. doi: 10.1111/1523-1747.ep12457923. [DOI] [PubMed] [Google Scholar]
  90. Grappel S. F., Bishop C. T., Blank F. Immunology of dermatophytes and dermatophytosis. Bacteriol Rev. 1974 Jun;38(2):222–250. doi: 10.1128/br.38.2.222-250.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Grappel S. F., Blank F., Bishop C. T. Circulating antibodies in dermatophytosis. Dermatologica. 1972;144(1):1–11. doi: 10.1159/000252089. [DOI] [PubMed] [Google Scholar]
  92. Grappel S. F., Blank F., Bishop C. T. Circulating antibodies in human favus. Dermatologica. 1971;143(5):271–276. doi: 10.1159/000252217. [DOI] [PubMed] [Google Scholar]
  93. Grappel S. F., Blank F., Bishop C. T. Immunological studies on dermatophytes. 3. Further analyses of the reactivities of neutral polysaccharides with rabbit antisera to Microsporum quinckeanum, Trichophyton schoenleinii, Trichophyton rubrum, Trichophyton interdigitale, and Trichophyton granulosum. J Bacteriol. 1968 Jul;96(1):70–75. doi: 10.1128/jb.96.1.70-75.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Grappel S. F., Blank F. Role of keratinases in dermatophytosis. I. Immune responses of guinea pigs infected with Trichophyton mentagrophytes and guinea pigs immunized with keratinases. Dermatologica. 1972;145(4):245–255. [PubMed] [Google Scholar]
  95. Grappel S. F., Buscavage C. A., Blank F., Bishop C. T. Comparative serological reactivities of twenty-seven polysaccharides from nine species of dermatophytes. Sabouraudia. 1970 Aug;8(2):116–125. doi: 10.1080/00362177085190741. [DOI] [PubMed] [Google Scholar]
  96. Green F., 3rd, Balish E. Suppression of in vitro lymphocyte transformation during an experimental dermatophyte infection. Infect Immun. 1979 Nov;26(2):554–562. doi: 10.1128/iai.26.2.554-562.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Green F., 3rd, Balish E. Trichophyton mentagrophytes dermatophytosis in germfree guinea pigs. J Invest Dermatol. 1980 Dec;75(6):476–480. doi: 10.1111/1523-1747.ep12524238. [DOI] [PubMed] [Google Scholar]
  98. Greenberg J. H., King R. D., Krebs S., Field R. A quantitative dermatophyte infection model in the guinea pig--a parallel to the quantitated human infection model. J Invest Dermatol. 1976 Dec;67(6):704–708. doi: 10.1111/1523-1747.ep12598588. [DOI] [PubMed] [Google Scholar]
  99. Grossman J., Baum J., Gluckman J., Fusner J., Condemi J. J. The effect of aging and acute illness on delayed hypersensitivity. J Allergy Clin Immunol. 1975 Apr;55(4):268–275. doi: 10.1016/0091-6749(75)90146-3. [DOI] [PubMed] [Google Scholar]
  100. HIRSCH J. G. Phagocytin: a bactericidal substance from polymorphonuclear leucocytes. J Exp Med. 1956 May 1;103(5):589–611. doi: 10.1084/jem.103.5.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Hafez M., el-Shamy S. Genetic susceptibility in pityriasis versicolor. Dermatologica. 1985;171(2):86–88. doi: 10.1159/000249397. [DOI] [PubMed] [Google Scholar]
  102. Hanifin J. M., Ray L. F., Lobitz W. C., Jr Immunological reactivity in dermatophytosis. Br J Dermatol. 1974 Jan;90(1):1–8. [PubMed] [Google Scholar]
  103. Hauser C. The interaction between Langerhans cells and CD4+ T cells. J Dermatol. 1992 Nov;19(11):722–725. doi: 10.1111/j.1346-8138.1992.tb03768.x. [DOI] [PubMed] [Google Scholar]
  104. Hay R. J. Chronic dermatophyte infections. I. Clinical and mycological features. Br J Dermatol. 1982 Jan;106(1):1–7. doi: 10.1111/j.1365-2133.1982.tb00895.x. [DOI] [PubMed] [Google Scholar]
  105. Hay R. J. Failure of treatment in chronic dermatophyte infections. Postgrad Med J. 1979 Sep;55(647):608–610. doi: 10.1136/pgmj.55.647.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Hay R. J. Genetic susceptibility to dermatophytosis. Eur J Epidemiol. 1992 May;8(3):346–349. doi: 10.1007/BF00158566. [DOI] [PubMed] [Google Scholar]
  107. Hay R. J., Shennan G. Chronic dermatophyte infections II. Antibody and cell-mediated immune responses. Br J Dermatol. 1982 Feb;106(2):191–198. doi: 10.1111/j.1365-2133.1982.tb00928.x. [DOI] [PubMed] [Google Scholar]
  108. Hermans P. E., Ulrich J. A., Markowitz H. Chronic mucocutaneous candidiasis as a surface expression of deep-seated abnormalities. Report of a syndrome of superficial candidiasis, absence of delayed hypersensitivity and aminoaciduria. Am J Med. 1969 Oct;47(4):503–519. doi: 10.1016/0002-9343(69)90181-8. [DOI] [PubMed] [Google Scholar]
  109. Herrod H. G. Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group. J Pediatr. 1990 Mar;116(3):377–382. doi: 10.1016/s0022-3476(05)82824-0. [DOI] [PubMed] [Google Scholar]
  110. Ho Y. M., Ng M. H., Huang C. T. Antibodies to germinating and yeast cells of Candida albicans in human and rabbit sera. J Clin Pathol. 1979 Apr;32(4):399–405. doi: 10.1136/jcp.32.4.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Hopfer R. L., Grappel S. F., Blank F. Antibodies with affinity for epithelial tissue in chronic dermatophytosis. Dermatologica. 1975;151(3):135–143. doi: 10.1159/000251326. [DOI] [PubMed] [Google Scholar]
  112. Hughes B. R. Tinea versicolor in immunosuppressed patients. J Am Acad Dermatol. 1988 Aug;19(2 Pt 1):357–358. doi: 10.1016/s0190-9622(88)80253-6. [DOI] [PubMed] [Google Scholar]
  113. Hunziker N., Brun R. Lack of delayed reaction in presence of cell-mediated immunity in trichophytin hypersensitivity. Arch Dermatol. 1980 Nov;116(11):1266–1268. [PubMed] [Google Scholar]
  114. Håkansson C., Faergemann J., Löwhagen G. B. Studies on the lipophilic yeast Pityrosporum ovale in HIV-seropositive and HIV-seronegative homosexual men. Acta Derm Venereol. 1988;68(5):422–426. [PubMed] [Google Scholar]
  115. Ikai K., Okano H., Horiguchi Y., Sakamoto Y. Leukotriene A4 hydrolase in human skin. J Invest Dermatol. 1994 Feb;102(2):253–257. doi: 10.1111/1523-1747.ep12371772. [DOI] [PubMed] [Google Scholar]
  116. Inaba K., Schuler G., Witmer M. D., Valinksy J., Atassi B., Steinman R. M. Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J Exp Med. 1986 Aug 1;164(2):605–613. doi: 10.1084/jem.164.2.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Johnson J. G., Jenkins M. K. Co-stimulatory functions of antigen-presenting cells. J Invest Dermatol. 1992 Nov;99(5):62S–65S. doi: 10.1111/1523-1747.ep12669010. [DOI] [PubMed] [Google Scholar]
  118. Jones H. E. Immune response and host resistance of humans to dermatophyte infection. J Am Acad Dermatol. 1993 May;28(5 Pt 1):S12–S18. doi: 10.1016/s0190-9622(09)80302-2. [DOI] [PubMed] [Google Scholar]
  119. Jones H. E., Reinhardt J. H., Rinaldi M. G. A clinical, mycological, and immunological survey for dermatophytosis. Arch Dermatol. 1973 Jul;108(1):61–65. [PubMed] [Google Scholar]
  120. Jones H. E., Reinhardt J. H., Rinaldi M. G. Acquired immunity to dermatophytes. Arch Dermatol. 1974 Jun;109(6):840–848. [PubMed] [Google Scholar]
  121. Jones H. E., Reinhardt J. H., Rinaldi M. G. Immunologic susceptibility to chronic dermatophytosis. Arch Dermatol. 1974 Aug;110(2):213–220. [PubMed] [Google Scholar]
  122. Jones H. E., Reinhardt J. H., Rinaldi M. G. Model dermatophytosis in naturally infected subjects. Arch Dermatol. 1974 Sep;110(3):369–374. [PubMed] [Google Scholar]
  123. Jones H. E., Rinaldi M. G., Chai H., Kahn G. Apparent cross-reactivity of airborne molds and the dermatophytic fungi. J Allergy Clin Immunol. 1973 Dec;52(6):346–351. doi: 10.1016/0091-6749(73)90093-6. [DOI] [PubMed] [Google Scholar]
  124. KLIGMAN A. M., GINSBERG D. Immunity of the adult scalp to infection with Microsporum audouinii. J Invest Dermatol. 1950 May;14(5):345–358. doi: 10.1038/jid.1950.43. [DOI] [PubMed] [Google Scholar]
  125. KLIGMAN A. M. Pathophysiology of ringworm infections in animals with skin cycles. J Invest Dermatol. 1956 Sep;27(3):171–185. doi: 10.1038/jid.1956.90. [DOI] [PubMed] [Google Scholar]
  126. KLIGMAN A. M. The pathogenesis of Tinea capitis due to Microsporum audouini and Microsporum canis. I. Gross observations following the inoculation of humans. J Invest Dermatol. 1952 Mar;18(3):231–246. doi: 10.1038/jid.1952.27. [DOI] [PubMed] [Google Scholar]
  127. Kaaman T. Cell-mediated reactivity in dermatophytosis: differences in skin responses to purified trichophytin in tinea pedis and tinea cruris. Acta Derm Venereol. 1981;61(2):119–123. [PubMed] [Google Scholar]
  128. Kaaman T., Petrini B., Wasserman J. In vivo and in vitro immune responses to trichophytin in dermatophytosis. Acta Derm Venereol. 1979;59(3):229–233. [PubMed] [Google Scholar]
  129. Kaaman T. The clinical significance of cutaneous reactions to trichophytin in dermatophytosis. Acta Derm Venereol. 1978;58(2):139–143. [PubMed] [Google Scholar]
  130. Kaaman T., von Stedingk L. V., von Stedingk M., Wasserman J. ELISA-determined serological reactivity against purified trichophytin in dermatophytosis. Acta Derm Venereol. 1981;61(4):313–317. [PubMed] [Google Scholar]
  131. Kamalam A., Senthamilselvi G., Ajithadas K., Thambiah A. S. Cutaneous trichosporosis. Mycopathologia. 1988 Mar;101(3):167–175. doi: 10.1007/BF00437035. [DOI] [PubMed] [Google Scholar]
  132. Kashima M., Takahashi H., Shimozuma M., Epstein W. L., Fukuyama K. Candidacidal activities of proteins partially purified from rat epidermis. Infect Immun. 1989 Jan;57(1):186–190. doi: 10.1128/iai.57.1.186-190.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Katoh T., Kagawa S., Ishimoto M. Malassezia intertrigo, a new clinical entity. Mycoses. 1988 Nov;31(11):558–562. doi: 10.1111/j.1439-0507.1988.tb04409.x. [DOI] [PubMed] [Google Scholar]
  134. Kauffman C. A., Shea M. J., Frame P. T. Invasive fungal infections in patients with chronic mucocutaneous candidiasis. Arch Intern Med. 1981 Jul;141(8):1076–1079. [PubMed] [Google Scholar]
  135. Kerbs S., Greenberg J., Jesrani K. Temporal correlation of lymphocyte blastogenesis, skin test responses and erythema during dermatophyte infections. Clin Exp Immunol. 1977 Mar;27(3):526–530. [PMC free article] [PubMed] [Google Scholar]
  136. King R. D., Cunico R. L., Maibach H. I., Greenberg J. H., West M. L., Jeppsen J. C. The effect of occlusion on carbon dioxide emission from human skin. Acta Derm Venereol. 1978;58(2):135–138. [PubMed] [Google Scholar]
  137. King R. D., Khan H. A., Foye J. C., Greenberg J. H., Jones H. E. Transferrin, iron, and dermatophytes. I. Serum dematophyte inhibitory component definitively identified as unsaturated transferrin. J Lab Clin Med. 1975 Aug;86(2):204–212. [PubMed] [Google Scholar]
  138. Kirkpatrick C. H. Host factors in defense against fungal infections. Am J Med. 1984 Oct 30;77(4D):1–12. [PubMed] [Google Scholar]
  139. Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971 Jun;74(6):955–978. doi: 10.7326/0003-4819-74-6-955. [DOI] [PubMed] [Google Scholar]
  140. Kirkpatrick C. H., Smith T. K. Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy. Ann Intern Med. 1974 Mar;80(3):310–320. doi: 10.7326/0003-4819-80-3-310. [DOI] [PubMed] [Google Scholar]
  141. Kirkpatrick C. H., Windhorst D. B. Mucocutaneous candidiasis and thymoma. Am J Med. 1979 Jun;66(6):939–945. doi: 10.1016/0002-9343(79)90448-0. [DOI] [PubMed] [Google Scholar]
  142. Klotz S. A., Drutz D. J., Huppert M., Johnson J. E. Pityrosporum folliculitis. Its potential for confusion with skin lesions of systemic candidiasis. Arch Intern Med. 1982 Nov;142(12):2126–2129. [PubMed] [Google Scholar]
  143. Klotz S. A. Malassezia furfur. Infect Dis Clin North Am. 1989 Mar;3(1):53–64. [PubMed] [Google Scholar]
  144. Knight A. G. A review of experimental human fungus infections. J Invest Dermatol. 1972 Oct;59(4):354–358. doi: 10.1111/1523-1747.ep12627413. [DOI] [PubMed] [Google Scholar]
  145. Knight S. C., Stagg A., Hill S., Fryer P., Griffiths S. Development and function of dendritic cells in health and disease. J Invest Dermatol. 1992 Nov;99(5):33S–38S. doi: 10.1111/1523-1747.ep12668601. [DOI] [PubMed] [Google Scholar]
  146. Koranda F. C., Dehmel E. M., Kahn G., Penn I. Cutaneous complications in immunosuppressed renal homograft recipients. JAMA. 1974 Jul 22;229(4):419–424. [PubMed] [Google Scholar]
  147. Kurimoto I., Arana M., Streilein J. W. Role of dermal cells from normal and ultraviolet B-damaged skin in induction of contact hypersensitivity and tolerance. J Immunol. 1994 Apr 1;152(7):3317–3323. [PubMed] [Google Scholar]
  148. Kutsch C. L., Norris D. A., Arend W. P. Tumor necrosis factor-alpha induces interleukin-1 alpha and interleukin-1 receptor antagonist production by cultured human keratinocytes. J Invest Dermatol. 1993 Jul;101(1):79–85. doi: 10.1111/1523-1747.ep12360119. [DOI] [PubMed] [Google Scholar]
  149. Lehner T., Wilton J. M., Ivanyi L. Immunodeficiencies in chronic muco-cutaneous candidosis. Immunology. 1972 May;22(5):775–787. [PMC free article] [PubMed] [Google Scholar]
  150. Lepper A. W., Anger H. S. Experimental bovine Trichophyton verrucosum infection. Comparison of the rate of epidermal cell proliferation and keratinisation in non-infected and reinoculated cattle. Res Vet Sci. 1976 Mar;20(2):117–121. [PubMed] [Google Scholar]
  151. Lepper A. W. Experimental bovine Trichophyton verrucosum infection. Preliminary clinical, immunological and histological observations in primarily infected and reinoculated cattle. Res Vet Sci. 1972 Mar;13(2):105–115. doi: 10.1016/S0034-5288(18)34054-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Lepper A. W. Experimental bovine Trichophyton verrucosum infection. The cellular responses in primary lesions of the skin resulting from surface or intradermal inoculation. Res Vet Sci. 1974 May;16(3):287–298. [PubMed] [Google Scholar]
  153. Lowinger-Seoane M., Torres-Rodríguez J. M., Madrenys-Brunet N., Aregall-Fusté S., Saballs P. Extensive dermatophytoses caused by Trichophyton mentagrophytes and Microsporum canis in a patient with AIDS. Mycopathologia. 1992 Dec;120(3):143–146. doi: 10.1007/BF00436391. [DOI] [PubMed] [Google Scholar]
  154. MARPLES M. J. The incidence of certain skin diseases in western Samoa: a preliminary survey. Trans R Soc Trop Med Hyg. 1950 Dec;44(3):319–332. doi: 10.1016/0035-9203(50)90060-5. [DOI] [PubMed] [Google Scholar]
  155. Mackenzie I. C. Relationship between mitosis and the ordered structure of the stratum corneum in mouse epidermis. Nature. 1970 May 16;226(5246):653–655. doi: 10.1038/226653a0. [DOI] [PubMed] [Google Scholar]
  156. Matsue H., Bergstresser P. R., Takashima A. Keratinocyte-derived IL-7 serves as a growth factor for dendritic epidermal T cells in mice. J Immunol. 1993 Dec 1;151(11):6012–6019. [PubMed] [Google Scholar]
  157. Matsue H., Cruz P. D., Jr, Bergstresser P. R., Takashima A. Cytokine expression by epidermal cell subpopulations. J Invest Dermatol. 1992 Nov;99(5):42S–45S. doi: 10.1111/1523-1747.ep12668619. [DOI] [PubMed] [Google Scholar]
  158. Matthews R. C., Burnie J. P., Fox A., Woods M., Tabaqchali S. Immunoblot analysis of the serological response in invasive Trichosporon beigelii and Blastoschizomyces capitatus infections. J Clin Microbiol. 1986 Feb;23(2):395–397. doi: 10.1128/jcm.23.2.395-397.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. McGregor J. M., Hamilton A. J., Hay R. J. Possible mechanisms of immune modulation in chronic dermatophytoses: an in vitro study. Br J Dermatol. 1992 Sep;127(3):233–238. doi: 10.1111/j.1365-2133.1992.tb00120.x. [DOI] [PubMed] [Google Scholar]
  160. McKay I. A., Leigh I. M. Epidermal cytokines and their roles in cutaneous wound healing. Br J Dermatol. 1991 Jun;124(6):513–518. doi: 10.1111/j.1365-2133.1991.tb04942.x. [DOI] [PubMed] [Google Scholar]
  161. McManus E. J., Bozdech M. J., Jones J. M. Role of the latex agglutination test for cryptococcal antigen in diagnosing disseminated infections with Trichosporon beigelii. J Infect Dis. 1985 Jun;151(6):1167–1169. doi: 10.1093/infdis/151.6.1167. [DOI] [PubMed] [Google Scholar]
  162. McNamara M. P., Wiessner J. H., Collins-Lech C., Hahn B. L., Sohnle P. G. Neutrophil death as a defence mechanism against Candida albicans infections. Lancet. 1988 Nov 19;2(8621):1163–1165. doi: 10.1016/s0140-6736(88)90234-6. [DOI] [PubMed] [Google Scholar]
  163. Metlay J. P., Puré E., Steinman R. M. Control of the immune response at the level of antigen-presenting cells: a comparison of the function of dendritic cells and B lymphocytes. Adv Immunol. 1989;47:45–116. doi: 10.1016/s0065-2776(08)60662-8. [DOI] [PubMed] [Google Scholar]
  164. Mobacken H., Lindholm L., Olling S. Deficient neutrophil function in a patient with chronic mucocutaneous candidiasis, thymoma and myasthenia gravis. Acta Derm Venereol. 1977;57(4):335–339. [PubMed] [Google Scholar]
  165. Modrzakowski M. C., Cooney M. H., Martin L. E., Spitznagel J. K. Bactericidal activity of fractionated granule contents from human polymorphonuclear leukocytes. Infect Immun. 1979 Mar;23(3):587–591. doi: 10.1128/iai.23.3.587-591.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Montes L. F. Systemic abnormalities and the intracellular site of infections of the stratum corneum. JAMA. 1970 Aug 31;213(9):1469–1472. [PubMed] [Google Scholar]
  167. Moore K. L., Thompson L. F. P-selectin (CD62) binds to subpopulations of human memory T lymphocytes and natural killer cells. Biochem Biophys Res Commun. 1992 Jul 15;186(1):173–181. doi: 10.1016/s0006-291x(05)80790-9. [DOI] [PubMed] [Google Scholar]
  168. Moore M. K., Hay R. J. Circulating antibodies and antigenic cross-reactivity in Hendersonula toruloidea and Scytalidium hyalinum infections. Br J Dermatol. 1986 Oct;115(4):435–445. doi: 10.1111/j.1365-2133.1986.tb06238.x. [DOI] [PubMed] [Google Scholar]
  169. Morris R. J., Fischer S. M., Slaga T. J. Evidence that the centrally and peripherally located cells in the murine epidermal proliferative unit are two distinct cell populations. J Invest Dermatol. 1985 Apr;84(4):277–281. doi: 10.1111/1523-1747.ep12265358. [DOI] [PubMed] [Google Scholar]
  170. Moser S. A., Domer J. E., Mather F. J. Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge. Infect Immun. 1980 Jan;27(1):140–149. doi: 10.1128/iai.27.1.140-149.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Moser S. A., Pollack J. D. Isolation of glycopeptides with skin test activity from dermatophytes. Infect Immun. 1978 Mar;19(3):1031–1046. doi: 10.1128/iai.19.3.1031-1046.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Murthy A. R., Lehrer R. I., Harwig S. S., Miyasaki K. T. In vitro candidastatic properties of the human neutrophil calprotectin complex. J Immunol. 1993 Dec 1;151(11):6291–6301. [PubMed] [Google Scholar]
  173. NELSON L. M., MCNIECE K. J. Recurrent Cushing's syndrome with Trichophyton rubrum infection. Arch Dermatol. 1959 Dec;80:700–704. doi: 10.1001/archderm.1959.01560240052006. [DOI] [PubMed] [Google Scholar]
  174. Nathan C. F., Kaplan G., Levis W. R., Nusrat A., Witmer M. D., Sherwin S. A., Job C. K., Horowitz C. R., Steinman R. M., Cohn Z. A. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. N Engl J Med. 1986 Jul 3;315(1):6–15. doi: 10.1056/NEJM198607033150102. [DOI] [PubMed] [Google Scholar]
  175. Nazzaro-Porro M., Passi S. Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol. 1978 Sep;71(3):205–208. doi: 10.1111/1523-1747.ep12547184. [DOI] [PubMed] [Google Scholar]
  176. Negi M., Tsuboi R., Matsui T., Ogawa H. Isolation and characterization of proteinase from Candida albicans: substrate specificity. J Invest Dermatol. 1984 Jul;83(1):32–36. doi: 10.1111/1523-1747.ep12261656. [DOI] [PubMed] [Google Scholar]
  177. Nestle F. O., Zheng X. G., Thompson C. B., Turka L. A., Nickoloff B. J. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol. 1993 Dec 1;151(11):6535–6545. [PubMed] [Google Scholar]
  178. Nordvall S. L., Lindgren L., Johansson S. G., Johansson S., Petrini B. IgE antibodies to Pityrosporum orbiculare and Staphylococcus aureus in patients with very high serum total IgE. Clin Exp Allergy. 1992 Aug;22(8):756–761. doi: 10.1111/j.1365-2222.1992.tb02815.x. [DOI] [PubMed] [Google Scholar]
  179. Odeberg H., Olsson I. Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein. Infect Immun. 1976 Dec;14(6):1276–1283. doi: 10.1128/iai.14.6.1276-1283.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Oppenheim J. J., Zachariae C. O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol. 1991;9:617–648. doi: 10.1146/annurev.iy.09.040191.003153. [DOI] [PubMed] [Google Scholar]
  181. Palmer D. L., Reed W. P. Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population. J Infect Dis. 1974 Aug;130(2):132–137. doi: 10.1093/infdis/130.2.132. [DOI] [PubMed] [Google Scholar]
  182. Palmer S. R., Bass J. W., Mandojana R., Wittler R. R. Tinea nigra palmaris and plantaris: a black fungus producing black spots on the palms and soles. Pediatr Infect Dis J. 1989 Jan;8(1):48–50. [PubMed] [Google Scholar]
  183. Papini M., Simonetti S. Humoral immunofluorescent antibodies in subjects with dermatophytosis. Mykosen. 1985 Sep;28(9):419–429. [PubMed] [Google Scholar]
  184. Parkinson E. K. Epidermal keratinocyte stem cells: their maintenance and regulation. Semin Cell Biol. 1992 Dec;3(6):435–444. doi: 10.1016/1043-4682(92)90014-m. [DOI] [PubMed] [Google Scholar]
  185. Peachey R. D., English M. P. An outbreak of Trichophyton rubrum infection in a geriatric hospital. Br J Dermatol. 1974 Oct;91(4):389–397. doi: 10.1111/j.1365-2133.1974.tb13076.x. [DOI] [PubMed] [Google Scholar]
  186. Peck S. M., Osserman K. E., Rule A. H. Intercellular antibodies: presence in a Trichophyton rubrum infection. J Invest Dermatol. 1972 Mar;58(3):133–138. doi: 10.1111/1523-1747.ep12538930. [DOI] [PubMed] [Google Scholar]
  187. Pentland A. P., Mahoney M. G. Keratinocyte prostaglandin synthesis is enhanced by IL-1. J Invest Dermatol. 1990 Jan;94(1):43–46. doi: 10.1111/1523-1747.ep12873337. [DOI] [PubMed] [Google Scholar]
  188. Podzorski R. P., Gray G. R., Nelson R. D. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J Immunol. 1990 Jan 15;144(2):707–716. [PubMed] [Google Scholar]
  189. Potten C. S. The epidermal proliferative unit: the possible role of the central basal cell. Cell Tissue Kinet. 1974 Jan;7(1):77–88. doi: 10.1111/j.1365-2184.1974.tb00401.x. [DOI] [PubMed] [Google Scholar]
  190. Potter B. S., Burgoon C. F., Jr, Johnson W. C. Pityrosporum folliculitis. Report of seven cases and review of the Pityrosporum organism relative to cutaneous disease. Arch Dermatol. 1973 Mar;107(3):388–391. doi: 10.1001/archderm.107.3.388. [DOI] [PubMed] [Google Scholar]
  191. Poulain D., Tronchin G., Vernes A., Delabre M., Biguet J. Experimental study of resistance to infection by Trichophyton mentagrophytes: demonstration of memory skin cells. J Invest Dermatol. 1980 Apr;74(4):205–209. doi: 10.1111/1523-1747.ep12541727. [DOI] [PubMed] [Google Scholar]
  192. Prose N. S. Cutaneous manifestations of pediatric HIV infection. Pediatr Dermatol. 1992 Dec;9(4):326–328. doi: 10.1111/j.1525-1470.1992.tb00618.x. [DOI] [PubMed] [Google Scholar]
  193. Péguet-Navarro J., Dalbiez-Gauthier C., Dezutter-Dambuyant C., Schmitt D. Dissection of human Langerhans cells' allostimulatory function: the need for an activation step for full development of accessory function. Eur J Immunol. 1993 Feb;23(2):376–382. doi: 10.1002/eji.1830230212. [DOI] [PubMed] [Google Scholar]
  194. Quindos G., Schneider J., Alvarez M., Ponton J., Cisterna R. Antibodies against Trichosporon beigelii in vaginal washings from asymptomatic women. J Med Microbiol. 1989 Mar;28(3):223–225. doi: 10.1099/00222615-28-3-223. [DOI] [PubMed] [Google Scholar]
  195. Rasmussen J. E., Ahmed A. R. Trichophytin reactions in children with tinea capitis. Arch Dermatol. 1978 Mar;114(3):371–372. [PubMed] [Google Scholar]
  196. Ray T. L., Wuepper K. D. Activation of the alternative (properdin) pathway of complement by Candida albicans and related species. J Invest Dermatol. 1976 Dec;67(6):700–703. doi: 10.1111/1523-1747.ep12598581. [DOI] [PubMed] [Google Scholar]
  197. Reid C. D., Fryer P. R., Clifford C., Kirk A., Tikerpae J., Knight S. C. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood. 1990 Sep 15;76(6):1139–1149. [PubMed] [Google Scholar]
  198. Reis e Sousa C., Stahl P. D., Austyn J. M. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med. 1993 Aug 1;178(2):509–519. doi: 10.1084/jem.178.2.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Rivas V., Rogers T. J. Studies on the cellular nature of Candida albicans-induced suppression. J Immunol. 1983 Jan;130(1):376–379. [PubMed] [Google Scholar]
  200. Roberts S. O. Pityriasis versicolor: a clinical and mycological investigation. Br J Dermatol. 1969 May;81(5):315–326. doi: 10.1111/j.1365-2133.1969.tb13990.x. [DOI] [PubMed] [Google Scholar]
  201. Rogers T. J., Balish E. Suppression of lymphocyte blastogenesis by Candida albicans. Clin Immunol Immunopathol. 1978 Jul;10(3):298–305. doi: 10.1016/0090-1229(78)90185-x. [DOI] [PubMed] [Google Scholar]
  202. Romani N., Kämpgen E., Koch F., Heufler C., Schuler G. Dendritic cell production of cytokines and responses to cytokines. Int Rev Immunol. 1990;6(2-3):151–161. doi: 10.3109/08830189009056626. [DOI] [PubMed] [Google Scholar]
  203. Root R. K., Cohen M. S. The microbicidal mechanisms of human neutrophils and eosinophils. Rev Infect Dis. 1981 May-Jun;3(3):565–598. doi: 10.1093/clinids/3.3.565. [DOI] [PubMed] [Google Scholar]
  204. Rose H. D., Kurup V. P. Colonization of hospitalized patients with yeast-like organisms. Sabouraudia. 1977 Nov;15(3):251–256. doi: 10.1080/00362177785380071. [DOI] [PubMed] [Google Scholar]
  205. Rothschild H., Wilson M., Lopez M., Salvaggio J., Bice D. An immunological investigation of a family with chronic mucocutaneous candidiasis. Int Arch Allergy Appl Immunol. 1976;52(1-4):291–296. doi: 10.1159/000231694. [DOI] [PubMed] [Google Scholar]
  206. Rycroft R. J., Valdimarsson H., Bannister L. H., Wells R. S. Chronic muco-cutaneous candidiasis of late onset, thymoma and myopathy. A report of four cases. Clin Exp Dermatol. 1976 Mar;1(1):59–74. doi: 10.1111/j.1365-2230.1976.tb01399.x. [DOI] [PubMed] [Google Scholar]
  207. SKARNES R. C., WATSON D. W. Characterization of leukin: an antibacterial factor from leucocytes active against gram-positive pathogens. J Exp Med. 1956 Dec 1;104(6):829–845. doi: 10.1084/jem.104.6.829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. STRAUSS J. S., KLIGMAN A. M. An experimental study of tinea pedis and onychomycosis of the foot. AMA Arch Derm. 1957 Jul;76(1):70–79. doi: 10.1001/archderm.1957.01550190074014. [DOI] [PubMed] [Google Scholar]
  209. Scheynius A., Faergemann J., Forsum U., Sjöberg O. Phenotypic characterization in situ of inflammatory cells in pityriasis (tinea) versicolor. Acta Derm Venereol. 1984;64(6):473–479. [PubMed] [Google Scholar]
  210. Schmitt C., Ballet J. J. Serum IgE and IgG antibodies to tetanus toxoid and candidin in immunodeficient children with the hyper-IgE syndrome. J Clin Immunol. 1983 Apr;3(2):178–183. doi: 10.1007/BF00915490. [DOI] [PubMed] [Google Scholar]
  211. Segal E. Vaccines for the management of dermatophyte and superficial yeast infections. Curr Top Med Mycol. 1989;3:36–49. doi: 10.1007/978-1-4612-3624-5_2. [DOI] [PubMed] [Google Scholar]
  212. Selsted M. E., Harwig S. S., Ganz T., Schilling J. W., Lehrer R. I. Primary structures of three human neutrophil defensins. J Clin Invest. 1985 Oct;76(4):1436–1439. doi: 10.1172/JCI112121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Serjeantson S., Lawrence G. Autosomal recessive inheritance of susceptibility to tinea imbricata. Lancet. 1977 Jan 1;1(8001):13–15. doi: 10.1016/s0140-6736(77)91653-1. [DOI] [PubMed] [Google Scholar]
  214. Shannon D. C., Johnson G., Rosen F. S., Austen K. F. Cellular reactivity to Candida albicans antigen. N Engl J Med. 1966 Sep 29;275(13):690–693. doi: 10.1056/NEJM196609292751302. [DOI] [PubMed] [Google Scholar]
  215. Sherwin W. K., Ross T. H., Rosenthal C. M., Petrozzi J. W. An immunosuppressive serum factor in widespread cutaneous dermatophytosis. Arch Dermatol. 1979 May;115(5):600–604. [PubMed] [Google Scholar]
  216. Shimizu Y., Shaw S., Graber N., Gopal T. V., Horgan K. J., Van Seventer G. A., Newman W. Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature. 1991 Feb 28;349(6312):799–802. doi: 10.1038/349799a0. [DOI] [PubMed] [Google Scholar]
  217. Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol. 1984 Aug;111(2):235–242. doi: 10.1111/j.1365-2133.1984.tb04050.x. [DOI] [PubMed] [Google Scholar]
  218. Simon J. C., Cruz P. D., Jr, Tigelaar R. E., Sontheimer R. D., Bergstresser P. R. Adhesion molecules CD11a, CD18, and ICAM-1 on human epidermal Langerhans cells serve a functional role in the activation of alloreactive T cells. J Invest Dermatol. 1991 Jan;96(1):148–151. doi: 10.1111/1523-1747.ep12515946. [DOI] [PubMed] [Google Scholar]
  219. Snyderman R., Altman L. C., Frankel A., Blaese R. M. Defective mononuclear leukocyte chemotaxis: a previously unrecognized immune dysfunction. Studies in a patient with chronic mucocutaneous candidiasis. Ann Intern Med. 1973 Apr;78(4):509–513. doi: 10.7326/0003-4819-78-4-509. [DOI] [PubMed] [Google Scholar]
  220. Sohnle P. G., Collins-Lech C. Activation of complement by Pityrosporum orbiculare. J Invest Dermatol. 1983 Feb;80(2):93–97. doi: 10.1111/1523-1747.ep12531644. [DOI] [PubMed] [Google Scholar]
  221. Sohnle P. G., Collins-Lech C. Analysis of the lymphocyte transformation response to Pityrosporum orbiculare in patients with tinea versicolor. Clin Exp Immunol. 1982 Sep;49(3):559–564. [PMC free article] [PubMed] [Google Scholar]
  222. Sohnle P. G., Collins-Lech C. Cell-mediated immunity to Pityrosporum orbiculare in tinea versicolor. J Clin Invest. 1978 Jul;62(1):45–53. doi: 10.1172/JCI109112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Sohnle P. G., Collins-Lech C., Huhta K. E. Class-specific antibodies in young and aged humans against organisms producing superficial fungal infections. Br J Dermatol. 1983 Jan;108(1):69–76. doi: 10.1111/j.1365-2133.1983.tb04580.x. [DOI] [PubMed] [Google Scholar]
  224. Sohnle P. G., Collins-Lech C., Huhta K. E. Kinetics of lymphokine production by lymphocytes from elderly humans. Gerontology. 1983;29(3):169–175. doi: 10.1159/000213110. [DOI] [PubMed] [Google Scholar]
  225. Sohnle P. G., Collins-Lech C. Relative antigenicity of P. orbiculare and C. albicans. J Invest Dermatol. 1980 Sep;75(3):279–283. doi: 10.1111/1523-1747.ep12523548. [DOI] [PubMed] [Google Scholar]
  226. Sohnle P. G., Collins-Lech C., Wiessner J. H. The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J Infect Dis. 1991 Jul;164(1):137–142. doi: 10.1093/infdis/164.1.137. [DOI] [PubMed] [Google Scholar]
  227. Sohnle P. G., Frank M. M., Kirkpatrick C. H. Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs. J Immunol. 1976 Aug;117(2):523–530. [PubMed] [Google Scholar]
  228. Sohnle P. G., Hahn B. L. Epidermal proliferation and the neutrophilic infiltrates of experimental cutaneous candidiasis in mice. Arch Dermatol Res. 1989;281(4):279–283. doi: 10.1007/BF00431063. [DOI] [PubMed] [Google Scholar]
  229. Sohnle P. G., Kirkpatrick C. H. Epidermal proliferation in the defense against experimental cutaneous candidiasis. J Invest Dermatol. 1978 Mar;70(3):130–133. doi: 10.1111/1523-1747.ep12258536. [DOI] [PubMed] [Google Scholar]
  230. Solcia E., Paulli M., Silini E., Fiocca R., Finzi G., Kindl S., Boveri E., Bosi F., Cornaggia M., Capella C. Cathepsin E in antigen-presenting Langerhans and interdigitating reticulum cells. Its possible role in antigen processing. Eur J Histochem. 1993;37(1):19–26. [PubMed] [Google Scholar]
  231. Sorensen G. W., Jones H. E. Immediate and delayed hypersensitivity in chronic dermatophytosis. Arch Dermatol. 1976 Jan;112(1):40–42. [PubMed] [Google Scholar]
  232. Stahl D., Svejgaard E. Lymphocyte transformation in vitro in acute dermatophytosis: a follow-up study. Acta Derm Venereol. 1982;62(4):289–293. [PubMed] [Google Scholar]
  233. Steinbakk M., Naess-Andresen C. F., Lingaas E., Dale I., Brandtzaeg P., Fagerhol M. K. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet. 1990 Sep 29;336(8718):763–765. doi: 10.1016/0140-6736(90)93237-j. [DOI] [PubMed] [Google Scholar]
  234. Stingl G. The skin: initiation and target site of immune responses. Recent Results Cancer Res. 1993;128:45–57. doi: 10.1007/978-3-642-84881-0_4. [DOI] [PubMed] [Google Scholar]
  235. Streilein J. W. Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol. 1983 Jun;80 (Suppl):12s–16s. doi: 10.1111/1523-1747.ep12536743. [DOI] [PubMed] [Google Scholar]
  236. Stössel H., Koch F., Kämpgen E., Stöger P., Lenz A., Heufler C., Romani N., Schuler G. Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med. 1990 Nov 1;172(5):1471–1482. doi: 10.1084/jem.172.5.1471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Sundstrom P. M., Kenny G. E. Characterization of antigens specific to the surface of germ tubes of Candida albicans by immunofluorescence. Infect Immun. 1984 Mar;43(3):850–855. doi: 10.1128/iai.43.3.850-855.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. Svejgaard E., Thomsen M., Morling N., Hein Christiansen A. H. Lymphocyte transformation in vitro in dermatophytosis. Acta Pathol Microbiol Scand C. 1976 Dec;84C(6):511–523. doi: 10.1111/j.1699-0463.1976.tb00063.x. [DOI] [PubMed] [Google Scholar]
  239. Swan J. W., Dahl M. V., Coppo P. A., Hammerschmidt D. E. Complement activation by trichophyton rubrum. J Invest Dermatol. 1983 Mar;80(3):156–158. doi: 10.1111/1523-1747.ep12533147. [DOI] [PubMed] [Google Scholar]
  240. Swerlick R. A., Garcia-Gonzalez E., Kubota Y., Xu Y. L., Lawley T. J. Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells. J Invest Dermatol. 1991 Aug;97(2):190–196. doi: 10.1111/1523-1747.ep12479643. [DOI] [PubMed] [Google Scholar]
  241. Swerlick R. A., Lawley T. J. Role of microvascular endothelial cells in inflammation. J Invest Dermatol. 1993 Jan;100(1):111S–115S. doi: 10.1111/1523-1747.ep12356595. [DOI] [PubMed] [Google Scholar]
  242. Symington F. W., Brady W., Linsley P. S. Expression and function of B7 on human epidermal Langerhans cells. J Immunol. 1993 Feb 15;150(4):1286–1295. [PubMed] [Google Scholar]
  243. Szepes E., Magyarlaki M., Battyáni Z., Schneider I. Immunohistological characterization of the cellular infiltrate in dermatophytosis. Mycoses. 1993 May-Jun;36(5-6):203–206. doi: 10.1111/j.1439-0507.1993.tb00751.x. [DOI] [PubMed] [Google Scholar]
  244. TINDALL J. P., SMITH J. G., Jr SKIN LESIONS OF THE AGED AND THEIR ASSOCIATION WITH INTERNAL CHANGES. JAMA. 1963 Dec 21;186:1039–1042. doi: 10.1001/jama.1963.03710120021004. [DOI] [PubMed] [Google Scholar]
  245. Tagami H., Natsume N., Aoshima T., Inoue F., Suehisa S., Yamada M. Analysis of transepidermal leukocyte chemotaxis in experimental dermatophytosis in guinea pigs. Arch Dermatol Res. 1982;273(3-4):205–217. doi: 10.1007/BF00409248. [DOI] [PubMed] [Google Scholar]
  246. Tagami H., Watanabe S., Ofuji S. Trichophytin contact sensitivity in guinea pigs with experimental dermatophytosis induced by a new inoculation method. J Invest Dermatol. 1973 Oct;61(4):237–241. doi: 10.1111/1523-1747.ep12676490. [DOI] [PubMed] [Google Scholar]
  247. Takeya K., Nomoto K., Matsumoto T., Miyake T., Himeno K. Chronic mucocutaneous candidiasis accompanied by enhanced antibody production. Clin Exp Immunol. 1976 Sep;25(3):497–500. [PMC free article] [PubMed] [Google Scholar]
  248. Takiuchi I., Higuchi D., Sei Y., Koga M. Isolation of an extracellular proteinase (keratinase) from Microsporum canis. Sabouraudia. 1982 Dec;20(4):281–288. [PubMed] [Google Scholar]
  249. Tamaki K., Fujiwara H., Levy R. B., Shearer G. M., Katz S. I. Hapten specific TNP-reactive cytotoxic effector cells using epidermal cells as targets. J Invest Dermatol. 1981 Aug;77(2):225–229. doi: 10.1111/1523-1747.ep12480043. [DOI] [PubMed] [Google Scholar]
  250. Tang A., Amagai M., Granger L. G., Stanley J. R., Udey M. C. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature. 1993 Jan 7;361(6407):82–85. doi: 10.1038/361082a0. [DOI] [PubMed] [Google Scholar]
  251. Test S. T., Lampert M. B., Ossanna P. J., Thoene J. G., Weiss S. J. Generation of nitrogen-chlorine oxidants by human phagocytes. J Clin Invest. 1984 Oct;74(4):1341–1349. doi: 10.1172/JCI111544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Teunissen M. B. Functional role of adhesion molecules LFA-3 and ICAM-1 on cultured human epidermal Langerhans cells in antigen-specific T-cell activation. J Invest Dermatol. 1992 Nov;99(5):77S–79S. doi: 10.1111/1523-1747.ep12669802. [DOI] [PubMed] [Google Scholar]
  253. Teunissen M. B., Rongen H. A., Bos J. D. Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activation. J Immunol. 1994 Apr 1;152(7):3400–3409. [PubMed] [Google Scholar]
  254. Thomas E. L., Lehrer R. I., Rest R. F. Human neutrophil antimicrobial activity. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S450–S456. doi: 10.1093/cid/10.supplement_2.s450. [DOI] [PubMed] [Google Scholar]
  255. Twomey J. J., Waddell C. C., Krantz S., O'reilly R., L'esperance P., Good R. A. Chronic mucocutaneous candidiasis with macrophage dysfunction, a plasma inhibitor, and co-existent aplastic anemia. J Lab Clin Med. 1975 Jun;85(6):968–977. [PubMed] [Google Scholar]
  256. Valdimarsson H., Higgs J. M., Wells R. S., Yamamura M., Hobbs J. R., Holt P. J. Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell Immunol. 1973 Mar;6(3):348–361. doi: 10.1016/0008-8749(73)90035-x. [DOI] [PubMed] [Google Scholar]
  257. Van Der Meer J. W., Leijh P. C., Van Den Barselaar, Van Furth R. Functions of phagocytic cells in chronic mucocutaneous candidiasis. Br Med J. 1978 Jan 21;1(6106):147–148. doi: 10.1136/bmj.1.6106.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  258. WOOD S. R., CRUICKSHANK C. N. The relation between trichophytin sensitivity and fungal infection. Br J Dermatol. 1962 Aug-Sep;74:329–336. doi: 10.1111/j.1365-2133.1962.tb13521.x. [DOI] [PubMed] [Google Scholar]
  259. Walters B. A., Chick J. E., Halliday W. J. Cell-mediated immunity and serum blocking factors in patients with chronic dermatophytic infections. Int Arch Allergy Appl Immunol. 1974;46(6):849–857. doi: 10.1159/000231187. [DOI] [PubMed] [Google Scholar]
  260. Weiss J., Elsbach P., Olsson I., Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem. 1978 Apr 25;253(8):2664–2672. [PubMed] [Google Scholar]
  261. Wilson B. D., Sohnle P. G. Participation of neutrophils and delayed hypersensitivity in the clearance of experimental cutaneous candidiasis in mice. Am J Pathol. 1986 May;123(2):241–249. [PMC free article] [PubMed] [Google Scholar]
  262. Yamazaki M., Yasui K., Kawai H., Miyagawa Y., Komiyama A., Akabane T. A monocyte disorder in siblings with chronic candidiasis. A combined abnormality of monocyte mobility and phagocytosis-killing ability. Am J Dis Child. 1984 Feb;138(2):192–196. doi: 10.1001/archpedi.1984.02140400074018. [DOI] [PubMed] [Google Scholar]
  263. Yohn J. J., Lucas J., Camisa C. Malassezia folliculitis in immunocompromised patients. Cutis. 1985 Jun;35(6):536–538. [PubMed] [Google Scholar]
  264. Yu R. J., Harmon S. R., Blank F. Isolation and purification of an extracellular keratinase of Trichophyton mentagrophytes. J Bacteriol. 1968 Oct;96(4):1435–1436. doi: 10.1128/jb.96.4.1435-1436.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES